Module 21 · Neuro-critical care

Raised ICP, neurotrauma and brain-stem death

NewPhase 2

Neurocritical care after brain injury: ICP and CPP targets with the SIBICC tiered approach, mannitol and hypertonic saline, severe TBI care by BTF 4th edition, post-craniotomy care, and brain-stem death certification and apnoea testing under Indian THOTA rules with Form 10.

5 topics

Drugs in this module

Doses written for this module's context. The same drug may read differently in another module.

Mannitol 20%

Osmotic diuretic

Indications
Raised ICP / impending herniation
Adult dose
0.25-1 g/kg IV over 15-20 min (1.25-5 mL/kg of 20%); repeat 4-6 hourly as needed.
Preparation (India)
20% 100 mL and 350 mL bottles (20 g/100 mL); use in-line filter, warm if crystallised.
Renal / hepatic
Avoid if serum osmolality > 320 mOsm/kg or osmolar gap > 20, hypovolaemia, or AKI.
Cautions
Osmotic diuresis → hypovolaemia and hypotension (replace urine losses); rebound ICP.
Monitoring
Serum Na, osmolality and osmolar gap before repeat doses; urine output; creatinine.

Hypertonic saline (3% or higher)

Osmotic agent

Indications
Raised ICP; herniation; hyponatraemia with neurological symptoms
Adult dose
3% NaCl: 2-5 mL/kg (150-250 mL) IV over 10-20 min bolus, or infusion to target Na 145-155 mmol/L. 23.4% NaCl 30 mL over 10-20 min via central line only (herniation).
Preparation (India)
3% NaCl 100 mL/500 mL bottles (available in India); 23.4% is rarely stocked. If 3% must be prepared on the unit, use only a pharmacy-approved recipe.
Cautions
Avoid Na rise > 10-12 mmol/L/24 h in chronic hyponatraemia; volume overload; hyperchloraemic acidosis. Peripheral 3% acceptable short-term through a good vein.
Monitoring
Na 4-6 hourly; stop if Na > 155-160 mmol/L.

Noradrenaline

Vasopressor

Indications
Maintain CPP / MAP in TBI and brain-stem death donor management
Adult dose
0.05-0.5 mcg/kg/min titrated to CPP 60-70 mmHg or MAP target.
Preparation (India)
4 mg in 50 mL = 80 mcg/mL.

Phenytoin

Antiepileptic

Indications
Prophylaxis of early post-traumatic seizures (BTF level IIA)
Adult dose
Load 15-20 mg/kg IV at ≤ 50 mg/min, then 100 mg every 8 h for 7 days.
Preparation (India)
50 mg/mL; dilute only in NS (precipitates in dextrose); in-line filter.
Cautions
Hypotension, arrhythmia during loading (ECG monitoring), purple glove syndrome, drug interactions.
Monitoring
Levels (corrected for albumin).

Levetiracetam

Antiepileptic

Indications
Prophylaxis of early post-traumatic seizures (7 days); seizure treatment
Adult dose
Prophylaxis: 500-1,000 mg IV/oral every 12 h for 7 days. Status epilepticus: 60 mg/kg IV (max 4,500 mg).
Preparation (India)
500 mg/5 mL vials; dilute in 100 mL NS over 15 min.
Renal / hepatic
Reduce maintenance if CrCl < 50 mL/min.
Cautions
Behavioural changes, somnolence.

Vasopressin

Vasopressor / antidiuretic

Indications
Diabetes insipidus and vasoplegia in brain-stem dead organ donors
Adult dose
0.5-2.4 units/h (≈ 0.01-0.04 units/min) infusion.
Preparation (India)
20 units/mL ampoules; 20 units in 50 mL = 0.4 units/mL.

Module references (9)

  1. 1

    Carney N, Totten AM, O'Reilly C, et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition. Neurosurgery 2017;80:6-15.

  2. 2

    Hawryluk GWJ, Aguilera S, Buki A, et al. A management algorithm for patients with intracranial pressure monitoring: the Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC). Intensive Care Med 2019;45:1783-94.

  3. 3

    Hutchinson PJ, Kolias AG, Timofeev IS, et al. Trial of decompressive craniectomy for traumatic intracranial hypertension (RESCUEicp). N Engl J Med 2016;375:1119-30.

  4. 4

    Andrews PJD, Sinclair HL, Rodriguez A, et al. Hypothermia for intracranial hypertension after traumatic brain injury (Eurotherm3235). N Engl J Med 2015;373:2403-12.

  5. 5

    CRASH trial collaborators. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial). Lancet 2004;364:1321-8.

  6. 6

    CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3). Lancet 2019;394:1713-23.

  7. 7

    Greer DM, Shemie SD, Lewis A, et al. Determination of brain death/death by neurologic criteria: the World Brain Death Project. JAMA 2020;324:1078-97.

  8. 8

    Ministry of Health and Family Welfare, Government of India. Transplantation of Human Organs and Tissues Act 1994 (amended 2011) and Transplantation of Human Organs and Tissues Rules, 2014. NOTTO.

  9. 9

    National Organ and Tissue Transplant Organisation (NOTTO). Form 10: Certification of brain-stem death (THOT Rules 2014). Download forms page.